Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

The heart failure syndrome has first been described as an emerging epidemic about 25
years ago. Today, because of a growing and ageing population, the total number of heart …

Background Five modifiable risk factors are associated with cardiovascular disease and
death from any cause. Studies using individual-level data to evaluate the regional and sex …

Aims To provide the first systematic analysis of the burden and underlying causes of heart
failure (HF) in 195 countries and territories from 1990 to 2017. Methods and results We …

Background The association of air pollution with multiple adverse health outcomes is
becoming well established, but its negative economic impact is less well appreciated. It is …

Background Estimating the risk of pre-existing comorbidities on coronavirus disease 2019
(COVID-19) mortality may promote the importance of targeting populations at risk to improve …

Hypertension is the leading cause of cardiovascular disease and premature death
worldwide. Owing to the widespread use of antihypertensive medications, global mean …

Evidence on what people eat globally is limited in scope and rigour, especially as it relates
to children and adolescents. This impairs target setting and investment in evidence-based …

This is an opportune time to publish the first KDIGO 2020 Clinical Practice Guideline for
Diabetes Management in Chronic Kidney Disease (CKD). Worldwide, the estimated number …

The current management of patients with primary psychosis worldwide is often remarkably
stereotyped. In almost all cases an antipsychotic medication is prescribed, with second …